The $7M gap between these two scientific titans tells a story about intellectual property strategy and timing. Einstein's advantage came posthumously through deliberate estate management: his name and image were systematized for licensing deals that generate $2M annually alone. Curie, by contrast, made her discoveries during an era when women scientists had minimal control over commercialization rights, and more importantly, she actively rejected the business side of science. She saw patents as corrupting scientific purity—a noble stance that was also financially devastating.

Here's where the real wealth divergence happened: Curie discovered radium and polonium but never patented the extraction process, meaning she captured zero of the pharmaceutical and industrial boom that followed. If she'd simply licensed her radium purification methods to companies—the way modern biotech founders do—she'd have accumulated licensing royalties that would dwarf Einstein's current net worth. Einstein, meanwhile, had his refrigeration patent (albeit uncommercialized) and more importantly, had his name become a global brand after his death, something his estate's trustees aggressively monetized starting in the 1950s.

The lesson isn't that Curie was bad with money—it's that she was intentionally indifferent to it while operating in a system that offered her fewer opportunities anyway. Einstein benefited from both smarter business decisions and the luck of dying when celebrity culture and merchandise were already lucrative. Curie's $1B opportunity cost illustrates how powerful the decision to commercialize (or not) is: one patent deal on radium applications could have made her wealthier than Einstein, regardless of gender. Instead, her legacy remains scientifically priceless but financially modest.